Home Tags PharmaMar

Tag: PharmaMar

PharmaMar and Seattle Genetics Sign Licensing Agreement for Fully Synthetic Marine-derived...

Earlier this week PharmaMar, an Madrid-based biopharmaceutical company developing innovative marine-derived anticancer drugs, signed an exclusive agreement with Seattle Genetics in which the company...

MI130004, a New ADC Using a Marine Compound, Shows Promising Therapeutic...

Over the last decade, antibody–drug conjugates or ADCs have emerged as powerful tool for the treatment of patients with cancer and hematological disorders.  These...

X